EPISODE · Aug 4, 2025 · 59 MIN
The Dot & Key Story | Building a top skin care brand with 500Cr+ scale & 15%+ EBITDA
from Brick by Brick: Building Insurgent Brands · host DSG Consumer Partners
In this episode, we sat down with Suyash Saraf, CEO and Co-founder of Dot & Key, one of India's most profitable beauty and personal care brands. With revenues exceeding 500 crores and EBITDA margins of 15%+, Dot & Key has achieved what most D2C brands struggle with - massive scale with concentrated focus on just two categories: moisturizers and sunscreens.In this candid conversation, Suyash reveals:→ Why they chose to dominate categories instead of diversifying→ How they built multiple hero products in sunscreen while competitors failed→ The real reasons behind their stagnation period and comeback strategy→ Their contrarian approach to capital efficiency and profitability-first growth→ Why they rejected the typical VC playbook and raised only 50 crores→ The organizational changes needed when scaling from 0-100 to 100-500 crores→ How they attracted top talent to Kolkata without a startup ecosystemFrom near-failure in 2021 to becoming every BPC founder's benchmark, this is the untold story of building India's most focused beauty empire.Whether you're a founder or just someone curious about the consumer startup world, this is a masterclass you don't want to miss.Visit DSGCP : https://www.dsgcp.comYou can also watch the full episode on the DSGCP website.
Embed this episode
What this episode covers
In this episode, we sat down with Suyash Saraf, CEO and Co-founder of Dot & Key, one of India's most profitable beauty and personal care brands. With revenues exceeding 500 crores and EBITDA margins of 15%+, Dot & Key has achieved what most D2C brands struggle with - massive scale with concentrated focus on just two categories: moisturizers and sunscreens. In this candid conversation, Suyash reveals: → Why they chose to dominate categories instead of diversifying → How they built mul...
NOW PLAYING
The Dot & Key Story | Building a top skin care brand with 500Cr+ scale & 15%+ EBITDA
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.